| Product Code: ETC6142889 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Argentina neuroprotective agents market, the import trend experienced a decline from 2023 to 2024, with a growth rate of -18.15%. However, the compound annual growth rate (CAGR) for the period 2020-2024 stood at 6.62%. This negative import momentum in 2024 could be attributed to shifting demand patterns or changes in market dynamics influencing trade flows.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Neuroprotective Agents Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Neuroprotective Agents Market Revenues & Volume, 2022 & 2032F |
3.3 Argentina Neuroprotective Agents Market - Industry Life Cycle |
3.4 Argentina Neuroprotective Agents Market - Porter's Five Forces |
3.5 Argentina Neuroprotective Agents Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.6 Argentina Neuroprotective Agents Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Argentina Neuroprotective Agents Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 Argentina Neuroprotective Agents Market Revenues & Volume Share, By Distribution Cahnnel, 2022 & 2032F |
4 Argentina Neuroprotective Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Argentina |
4.2.2 Growing awareness about neuroprotective agents and their benefits |
4.2.3 Technological advancements in the field of neuroprotection |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of neuroprotective agents |
4.3.2 High cost associated with neuroprotective treatments |
4.3.3 Limited accessibility to advanced neuroprotective therapies in certain regions of Argentina |
5 Argentina Neuroprotective Agents Market Trends |
6 Argentina Neuroprotective Agents Market, By Types |
6.1 Argentina Neuroprotective Agents Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Argentina Neuroprotective Agents Market Revenues & Volume, By Drug Class, 2022-2032F |
6.1.3 Argentina Neuroprotective Agents Market Revenues & Volume, By Anesthetics, 2022-2032F |
6.1.4 Argentina Neuroprotective Agents Market Revenues & Volume, By Antagonists, 2022-2032F |
6.1.5 Argentina Neuroprotective Agents Market Revenues & Volume, By Antidepressants, 2022-2032F |
6.1.6 Argentina Neuroprotective Agents Market Revenues & Volume, By Cytokines, 2022-2032F |
6.1.7 Argentina Neuroprotective Agents Market Revenues & Volume, By Others, 2022-2032F |
6.2 Argentina Neuroprotective Agents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Argentina Neuroprotective Agents Market Revenues & Volume, By Alzheimer's disease, 2022-2032F |
6.2.3 Argentina Neuroprotective Agents Market Revenues & Volume, By Dementia, 2022-2032F |
6.2.4 Argentina Neuroprotective Agents Market Revenues & Volume, By Epilepsy, 2022-2032F |
6.2.5 Argentina Neuroprotective Agents Market Revenues & Volume, By Multiple sclerosis, 2022-2032F |
6.2.6 Argentina Neuroprotective Agents Market Revenues & Volume, By Others, 2022-2032F |
6.3 Argentina Neuroprotective Agents Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Argentina Neuroprotective Agents Market Revenues & Volume, By Oral, 2022-2032F |
6.3.3 Argentina Neuroprotective Agents Market Revenues & Volume, By Topical, 2022-2032F |
6.3.4 Argentina Neuroprotective Agents Market Revenues & Volume, By Epidural, 2022-2032F |
6.3.5 Argentina Neuroprotective Agents Market Revenues & Volume, By Intravenous, 2022-2032F |
6.4 Argentina Neuroprotective Agents Market, By Distribution Cahnnel |
6.4.1 Overview and Analysis |
6.4.2 Argentina Neuroprotective Agents Market Revenues & Volume, By Hospital Pharmacies, 2022-2032F |
6.4.3 Argentina Neuroprotective Agents Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
6.4.4 Argentina Neuroprotective Agents Market Revenues & Volume, By Drug Stores, 2022-2032F |
6.4.5 Argentina Neuroprotective Agents Market Revenues & Volume, By Online Pharmacies, 2022-2032F |
7 Argentina Neuroprotective Agents Market Import-Export Trade Statistics |
7.1 Argentina Neuroprotective Agents Market Export to Major Countries |
7.2 Argentina Neuroprotective Agents Market Imports from Major Countries |
8 Argentina Neuroprotective Agents Market Key Performance Indicators |
8.1 Number of clinical trials for neuroprotective agents in Argentina |
8.2 Adoption rate of neuroprotective agents among healthcare providers |
8.3 Investment in research and development of new neuroprotective agents |
9 Argentina Neuroprotective Agents Market - Opportunity Assessment |
9.1 Argentina Neuroprotective Agents Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.2 Argentina Neuroprotective Agents Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Argentina Neuroprotective Agents Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 Argentina Neuroprotective Agents Market Opportunity Assessment, By Distribution Cahnnel, 2022 & 2032F |
10 Argentina Neuroprotective Agents Market - Competitive Landscape |
10.1 Argentina Neuroprotective Agents Market Revenue Share, By Companies, 2025 |
10.2 Argentina Neuroprotective Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here